Onabotulinum toxin A for the treatment of headache in service members with a history of mild traumatic brain injury: A cohort study

Headache

Volumn 55, Issue 3, 2015, Pages 395-406

  Yerry, Juanita A ^a   Kuehn, Devon ^a   Finkel, Alan G ^a,b,c  

^a WOMACK ARMY MEDICAL CENTER   (United States)

^b Defense and Veterans Brain Injury Center   (United States)

^c Carolina Headache Institute   (United States)

Author keywords

botulinum toxin; chronic migraine; headache; migraine; military; traumatic brain injury

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; ARMY; ARTICLE; BLAST INJURY; BLUNT TRAUMA; CERVICAL DYSTONIA; CLINICAL EVALUATION; COHORT ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; FIGHTING; HEADACHE; HEARING IMPAIRMENT; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MUSCLE SPASM; NECK PAIN; NEUROLOGIC EXAMINATION; PAIN ASSESSMENT; POSTTRAUMATIC HEADACHE; PRIORITY JOURNAL; SLEEP DISORDER; THORAX PAIN; TORTICOLLIS; TRAFFIC ACCIDENT; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE; BRAIN INJURY; CASE REPORT; COMPLICATION; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXINS, TYPE A; BRAIN INJURIES; COHORT STUDIES; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; TREATMENT OUTCOME;

EID: 84924569177     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12495     Document Type: Article

References (72)

1. Scher AI, Monteith TS,. Epidemiology and classification of post-traumatic headache: What do we know and how do we move forward? Comment on Lucas et al., "Prevalence and characterization of headache following mild TBI." Cephalalgia. 2014; 34: 83-85.
2. Lucas S, Hoffman JM, Bell KR, Dikmen S,. A prospective study of prevalence and characterization of headache following mild traumatic brain injury. Cephalalgia. 2014; 34: 93-102.
3. Theeler B, Lucas S, Riechers RG, Ruff RL,. Post-traumatic headaches in civilians and military personnel: A comparative, clinical review. Headache. 2013; 53: 881-900.
4. Walker WC, Marwitz JH, Wilk AR, et al. Prediction of headache severity (density and functional impact) after traumatic brain injury: A longitudinal multicenter study. Cephalalgia. 2013; 33: 998-1008.
5. Lucas S, Hoffman JM, Bell KR, Walker W, Dikmen S,. Characterization of headache after traumatic brain injury. Cephalalgia. 2012; 32: 600-606.
6. Lucas S,. Headache management in concussion and mild traumatic brain injury. PMR. 2011; 3 (10 Suppl. 2): S406-S412.
7. Hoffman JM, Lucas S, Dikmen S, et al. Natural history of headache after traumatic brain injury. J Neurotrauma. 2011; 28: 1719-1725.
8. Armed Forces Health Surveillance Center, Medical Surveillance Monthly Report. 2013;20:9-13.
9. Hoge CW, Castro CA,. Blast-related traumatic brain injury in U.S. military personnel. N Engl J Med. 2011; 365: 860, author reply 860-1.
10. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA,. Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med. 2008; 358: 453-463.
11. Scher AI, Finkel AG, Terrio H, et al. Headache disorders in recently deployed soldiers with and without traumatic brain injury. Presented at the 63 Annual Meeting of the American Academy of Neurology, Honolulu, Hawaii, 2011.
12. Finkel AG, Yerry J, Scher A, Choi YS,. Headaches in soldiers with mild traumatic brain injury: Findings and phenomenologic descriptions. Headache. 2012; 52: 957-965.
13. Couch JR, Lipton RB, Stewart WF, Scher AI,. Head or neck injury increases the risk of chronic daily headache: A population-based study. Neurology. 2007; 69: 1169-1177.
14. Theeler BJ, Mercer R, Erickson JC,. Prevalence and impact of migraine among US Army soldiers deployed in support of Operation Iraqi Freedom. Headache. 2008; 48: 876-882.
15. Neely ET, Midgette LA, Scher AI,. Clinical review and epidemiology of headache disorders in US service members: With emphasis on post-traumatic headache. Headache. 2009; 49: 1089-1096.
16. Theeler BJ, Erickson JC,. Mild head trauma and chronic headaches in returning US soldiers. Headache. 2009; 49: 529-534.
17. Vargas BB,. Posttraumatic headache in combat soldiers and civilians: What factors influence the expression of tension-type versus migraine headache? Curr Pain Headache Rep. 2009; 13: 470-473.
18. Baandrup L, Jensen R,. Chronic post-traumatic headache-a clinical analysis in relation to the international headache classification 2nd edition. Cephalalgia. 2005; 25: 132-138.
19. Bryan CJ, Hernandez AM,. Predictors of post-traumatic headache severity among deployed military personnel. Headache. 2011; 51: 945-953.
20. Cox AL, Engel CC, Castro CA,. Mild traumatic brain injury in U.S. soldiers returning from Iraq. N Engl J Med. 2008; 358: 453-456.
21. Haas DC,. Chronic post-traumatic headaches classified and compared with natural headaches. Cephalalgia. 1996; 16: 486-493.
22. Theeler BJ, Flynn FG, Erickson JC,. Headaches after concussion in US soldiers returning from Iraq or Afghanistan. Headache. 2010; 50: 1262-1272.
23. Wilk JE, Thomas JL, McGurk DM, Riviere LA, Castro CA, Hoge CW,. Mild traumatic brain injury (concussion) during combat: Lack of association of blast mechanism with persistent postconcussive symptoms. J Head Trauma Rehabil. 2010; 25: 9-14.
24. Belanger HG, Proctor-Weber Z, Kretzmer T, Kim M, Frsench LM, Vanderploeg RD,. Symptom complaints following reports of blast versus non-blast mild TBI: Does mechanism of injury matter? Clin Neuropsychol. 2011; 1: 1-14.
25. Ruff RL, Ruff SS, Wang XF,. Headaches among Operation Iraqi Freedom/Operation Enduring Freedom veterans with mild traumatic brain injury associated with exposures to explosions. J Rehabil Res Dev. 2008; 45: 941-952.
26. Patil VK, St Andre JR, Crisan E, et al. Prevalence and treatment of headaches in veterans with mild traumatic brain injury. Headache. 2011; 51: 1112-1121.
27. Erickson JC,. Treatment outcomes of chronic post-traumatic headaches after mild head trauma in US soldiers: An observational study. Headache. 2011; 51: 932-944.
28. Cohen SP, Plunkett AR, Wilkinson I, et al. Headaches during war: Analysis of presentation, treatment, and factors associated with outcome. Cephalalgia. 2012; 32: 94-108.
29. International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 86-87.
30. Smitherman TA, Burch R, Sheikh H, Loder E,. The prevalence, impact, and treatment of migraine and severe headaches in the United States: A review of statistics from national surveillance studies. Headache. 2013; 53: 427-436.
31. Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB,. Cost and predictors of lost productive time in chronic migraine and episodic migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Value Health. 2013; 16: 31-38.
32. Bloudek LM, Stokes M, Buse DC, et al. Cost of healthcare for patients with migraine in five European countries: Results from the International Burden of Migraine Study (IBMS). J Headache Pain. 2012; 13: 361-378.
33. Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011; 31: 301-315.
34. Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW,. Duration of migraine is a predictor for response to botulinum toxin type A. Headache. 2005; 45: 308-314.
35. Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD,. Chronic migraine-classification, characteristics and treatment. Nat Rev Neurol. 2012; 8: 162-171.
36. Negro A, Rocchietti-March M, Fiorillo M, Martelletti P,. Chronic migraine: Current concepts and ongoing treatments. Eur Rev Med Pharmacol Sci. 2011; 15: 1401-1420.
37. Diener HC, Dodick DW, Aurora SK, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010; 30: 804-814.
38. Zatzick DF, Rivara FP, Jurkovich GJ, et al. Multisite investigation of traumatic brain injuries, posttraumatic stress disorder, and self-reported health and cognitive impairments. Arch Gen Psychiatry. 2010; 67: 1291-1300.
39. Thomas JL, Wilk JE, Riviere LA, McGurk D, Castro CA, Hoge CW,. Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq. Arch Gen Psychiatry. 2010; 67: 614-623.
40. Hoge CW, Wilk JE, Herrell R,. Methodological issues in mild traumatic brain injury research. Arch Phys Med Rehabil. 2010; 91: 963-964.
41. Afari N, Harder LH, Madra NJ, et al. PTSD, combat injury, and headache in veterans returning from Iraq/Afghanistan. Headache. 2009; 49: 1267-1276.
42. Halbauer JD, Ashford JW, Zeitzer JM, Adamson MM, Lew HL, Yesavage JA,. Neuropsychiatric diagnosis and management of chronic sequelae of war-related mild to moderate traumatic brain injury. J Rehabil Res Dev. 2009; 46: 757-796.
43. Belanger HG, Kretzmer T, Vanderploeg RD, French LM,. Symptom complaints following combat-related traumatic brain injury: Relationship to traumatic brain injury severity and posttraumatic stress disorder. J Int Neuropsychol Soc. 2010; 16: 194-199.
44. Rosenthal JF, Erickson JC,. Post-traumatic stress disorder in U.S. soldiers with post-traumatic headache. Headache. 2013; 53: 1564-1572.
45. Lippert-Grüner M,. Botulinum toxin in the treatment of post-traumatic headache-case study. Neurol Neurochir Pol. 2012; 46: 591-594.
46. Becker WJ, Chitsantikul P,. Cervicogenic headache and onabotulinumtoxinA: Where do we stand? Cephalalgia. 2011; 31: 979-980.
47. Linde M, Hagen K, Salvesen Ø, Gravdahl GB, Helde G, Stovner LJ,. Onabotulinum toxin A treatment of cervicogenic headache: A randomised, double-blind, placebo-controlled crossover study. Cephalalgia. 2011; 31: 797-807.
48. He MW, Ni JX, Guo YN, Wang Q, Yang LQ, Liu JJ,. Continuous epidural block of the cervical vertebrae for cervicogenic headache. Chin Med J (Engl). 2009; 122: 427-430.
49. Kapural L, Stillman M, Kapural M, McIntyre P, Guirgius M, Mekhail N,. Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: A case series. Pain Pract. 2007; 7: 337-340.
50. Moon J, Ahmed K, Garza I,. Case series of sixteen patients with nummular headache. Cephalalgia. 2010; 30: 1527-1530.
51. Yamazaki Y, Kobatake K,. Successful treatment of nummular headache with Neurotropin®. J Headache Pain. 2011; 12: 661-662.
52. Dusitanond P, Young W,. Botulinum toxin type A's efficacy in nummular headache. Headache. 2008; 48: 1379.
53. Mathew NT, Kailasam J, Meadors L,. Botulinum toxin type A for the treatment of nummular headache: Four case studies. Headache. 2008; 48: 442-447.
54. Finkel AG,. Botulinum toxin and the treatment of headache: A clinical review. Headache. 2011; 51: 1565-1572.
55. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33: 629-808.
56. Theeler BJ, Erickson JC,. Post-traumatic headaches: Time for a revised classification? Cephalalgia. 2012; 32: 589-591.
57. Ferguson PL, Smith GM, Wannamaker BB, Thurman DJ, Pickelsimer EE, Selassie AW,. A population-based study of risk of epilepsy after hospitalization for traumatic brain injury. Epilepsia. 2010; 51: 891-898.
58. Emanuelson I, Uvebrant P,. Occurrence of epilepsy during the first 10 years after traumatic brain injury acquired in childhood up to the age of 18 years in the south western Swedish population-based series. Brain Inj. 2009; 23: 612-616.
59. Asikainen I, Kaste M, Sarna S,. Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: Brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia. 1999; 40: 584-589.
60. Christensen J, Pedersen MG, Pedersen CB, Sidenius P, Olsen J, Vestergaard M,. Long-term risk of epilepsy after traumatic brain injury in children and young adults: A population-based cohort study. Lancet. 2009; 373: 1105-1110.
61. Annegers JF, Hauser WA, Coan SP, Rocca WA,. A population-based study of seizures after traumatic brain injuries. N Engl J Med. 1998; 338: 20-24.
62. Wilson J, Jones M, Fear NT, et al. Is previous psychological health associated with the likelihood of Iraq War deployment? An investigation of the "healthy warrior effect." Am J Epidemiol. 2009; 169: 1362-1369.
63. Larson GE, Highfill-McRoy RM, Booth-Kewley S,. Psychiatric diagnoses in historic and contemporary military cohorts: Combat deployment and the healthy warrior effect. Am J Epidemiol. 2008; 167: 1269-1276.
64. Ryan NP, Anderson V, Godfrey C, et al. Predictors of very long-term socio-cognitive function after pediatric traumatic brain injury (TBI): Support for the vulnerability of the immature "social brain." J Neurotrauma. 2014; 31: 649-657.
65. Rapp PE, Rosenberg BM, Keyser DO, et al. Patient characterization protocols for psychophysiological studies of traumatic brain injury and post-TBI psychiatric disorders. Front Neurol. 2013; 4: 91.
66. Sela-Kaufman M, Rassovsky Y, Agranov E, Levi Y, Vakil E,. Premorbid personality characteristics and attachment style moderate the effect of injury severity on occupational outcome in traumatic brain injury: Another aspect of reserve. J Clin Exp Neuropsychol. 2013; 35: 584-595.
67. McCauley SR, Wilde EA, Miller ER, et al. Preinjury resilience and mood as predictors of early outcome following mild traumatic brain injury. J Neurotrauma. 2013; 30: 642-652.
68. Silberstein SD, Göbel H, Jensen R, et al. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: A multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia. 2006; 26: 790-800.
69. Mathew NT, Frishberg BM, Gawel M, et al. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: A randomized, double-blind, placebo-controlled trial. Headache. 2005; 45: 293-307.
70. Sycha T, Kranz G, Auff E, Schnider P,. Botulinum toxin in the treatment of rare head and neck pain syndromes: A systematic review of the literature. J Neurol. 2004; 251 (Suppl. 1): I19-I30.
71. Kosaras B, Jakubowski M, Kainz V, Burstein R,. Sensory innervation of the calvarial bones of the mouse. J Comp Neurol. 2009; 515: 331-348.
72. Burstein R, Cutrer MF, Yarnitsky D,. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000; 123 (Pt 8): 1703-1709.